RxSight, Inc.
NASDAQ:RXST
50.85 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 9.692 | 11.834 | 24.361 | 13.994 | 7.958 |
| Short Term Investments
| 117.49 | 93.968 | 134.971 | 54.981 | 72.71 |
| Cash and Short Term Investments
| 127.182 | 105.802 | 159.332 | 68.975 | 80.668 |
| Net Receivables
| 20.281 | 10.956 | 4.862 | 2.865 | 0.789 |
| Inventory
| 17.421 | 14.835 | 8.032 | 8.288 | 7.219 |
| Other Current Assets
| 3.523 | 2.962 | 4.069 | 1.372 | 1.523 |
| Total Current Assets
| 168.407 | 134.555 | 176.295 | 81.5 | 90.199 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 13.285 | 14.081 | 15.501 | 18.606 | 19.25 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.711 | 0.761 | 0.811 | 0.461 | 0.872 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.147 | 0.767 | 0.114 | 0.11 | 0.111 |
| Total Non-Current Assets
| 14.143 | 15.609 | 16.426 | 19.177 | 20.233 |
| Total Assets
| 182.55 | 150.164 | 192.721 | 100.677 | 110.432 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 3.863 | 2.595 | 1.689 | 1.134 | 2.199 |
| Short Term Debt
| 1.801 | 1.97 | 1.529 | 1.274 | 0.99 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 2.045 | 1.348 | 0.618 | 0.438 | 0.378 |
| Other Current Liabilities
| 13.194 | 11.324 | 7.241 | 8.754 | 4.89 |
| Total Current Liabilities
| 20.903 | 17.237 | 11.077 | 11.6 | 8.457 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 1.211 | 43.025 | 43.402 | 29.478 | 4.526 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.074 | 0 | 0 | 357.128 | 402.06 |
| Total Non-Current Liabilities
| 1.285 | 43.025 | 43.402 | 386.606 | 406.586 |
| Total Liabilities
| 22.188 | 60.262 | 54.479 | 398.206 | 415.043 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 192.721 | 353.3 | 327.581 |
| Common Stock
| 0.036 | 0.028 | 0.027 | 80.78 | 56.422 |
| Retained Earnings
| -594.64 | -546.032 | -479.276 | -430.588 | -419.855 |
| Accumulated Other Comprehensive Income/Loss
| -0.005 | -0.095 | -0.02 | -0.003 | 0.046 |
| Other Total Stockholders Equity
| 754.971 | 636.001 | 424.79 | -301.018 | -268.805 |
| Total Shareholders Equity
| 160.362 | 89.902 | 138.242 | -297.529 | -304.611 |
| Total Equity
| 160.362 | 89.902 | 138.242 | -297.529 | -304.611 |
| Total Liabilities & Shareholders Equity
| 182.55 | 150.164 | 192.721 | 100.677 | 110.432 |